Daniella Beckman - Insider Trading & Ownership

Location
C/O Idenix Pharmaceuticals, Inc., One Kendall Square, Bldg. 1400, Cambridge, MA
Summary
The estimated net worth of Daniella Beckman is at least $475K dollars as of July 21, 2025. Daniella Beckman is the Chief Financial Officer of Tango Therapeutics, Inc. and owns shares of Tango Therapeutics, Inc. (TNGX) stock worth about $475K.
Signature
/s/ Melissa Masse, Attorney-in-Fact
All Insider Reports
All Insider Reports

Ownership of Daniella Beckman

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
TNGX Tango Therapeutics, Inc. Chief Financial Officer $475K -$25.3K -5.05% Feb 4, 2025
BPMC Blueprint Medicines Corp Director $0 Jul 17, 2025
TBIO Translate Bio, Inc. Director Sep 14, 2021
UPB Upstream Bio, Inc. Director Jun 10, 2025
VOR Vor Biopharma Inc. Director May 22, 2025

Insider Transactions Reported by Daniella Beckman:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.